SCHEMBL4330707

SCHEMBL4330707

O=C1/C(=C/c2c(-c3ccccc3)[nH]c3ccccc23)Oc2cc(O)ccc21

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 7/20 0.72
MTOR P42345 7/20 0.72
PIK3CG P48736 4/20 0.72
TYR P14679 3/20 0.56
MAOB P27338 4/20 0.54
MAOA P21397 3/20 0.54
CISD1 Q9NZ45 1/20 0.54
HASPIN Q8TF76 1/20 0.49
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
USP2 O75604 1/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
RECQL P46063 2/20 0.48
POLB P06746 1/20 0.48
RAB9A P51151 1/20 0.48
KDM4E B2RXH2 1/20 0.48
PSMD14 O00487 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1428507 1.00 PIK3CA (0.72) PIK3CAMTORPIK3CGTYRMAOB
SCHEMBL4316023 0.92 PIK3CA (0.74) PIK3CAMTORPIK3CGTYRMAOB
SCHEMBL1428523 0.92 PIK3CA (0.74) PIK3CAMTORPIK3CGTYRMAOB
SCHEMBL4325800 0.92 PIK3CA (0.74) PIK3CAMTORPIK3CGTYRMAOB
SCHEMBL1428537 0.92 PIK3CA (0.74) PIK3CAMTORPIK3CGTYRMAOB
SCHEMBL4321127 0.89 PIK3CA (0.74) PIK3CAMTORPIK3CGTYRMAOB
SCHEMBL1429291 0.89 PIK3CA (0.74) PIK3CAMTORPIK3CGTYRMAOB
SCHEMBL3218201 0.87 PIK3CA (0.76) PIK3CAMTORPIK3CGTYRMAOB
SCHEMBL1429009 0.87 PIK3CA (0.76) PIK3CAMTORPIK3CGTYRMAOB
SCHEMBL4324436 0.86 PIK3CA (0.64) PIK3CAMTORPIK3CGMAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090311217-A1 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES WYETH (US) 2009-12-17 US claimed
US-20090311217-A1 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES WYETH (US) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090311217-A1 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES MTOR, RICTOR, PDPK1 PIK3CA 4/4885MTOR 1/4885PIK3CG 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.